ClinicalThought

Share

Program Content

Activities

  • PARPi in PCa: Key Issues
    My Thoughts on Key Issues With PARP Inhibitors for Prostate Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 26, 2022

    Expires: April 25, 2023

Provided by

ProCE Banner

Supporters

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.